1. Home
  2. Clinical Topics
  3. FDA updates Tasigna label to include stop treatment options
Clinical TopicsDrugs and DevicesWeb Exclusives
leukemia fda stop treatment tasigna

FDA updates Tasigna label to include stop treatment options

Share

On Dec. 22, the U.S. Food and Drug Administration (FDA) updated the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response.

Read more via Fda.gov.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts